Is cognitive–behavioral therapy more effective than other therapies?A meta-analytic review

Tolin, David F.

doi:10.1016/j.cpr.2010.05.003

Cited by 529 publications

(343 citation statements)

References 71 publications

Supporting

Mentioning

305

Contrasting

Unclassified

Order By: Relevance

“…Our findings are in line with Manicavasgar et al (25), demonstrating effectiveness of group MBCT and CBT in reducing depression. These and our findings show that CBT is effective but not superior to some other active treatments (38). Our results are innovative, as this is the first RCT study on the effectiveness of the individual delivery of MBCT, with currently only evidence for the effectiveness of group-based MBCT.…”

Section: Discussionmentioning

confidence: 53%

Individual Mindfulness-Based Cognitive Therapy and Cognitive Behavior Therapy for Treating Depressive Symptoms in Patients With Diabetes: Results of a Randomized Controlled Trial

et al. 2014

View full text Add to dashboard Cite

OBJECTIVEDepression is a common comorbidity of diabetes, undesirably affecting patients' physical and mental functioning. Psychological interventions are effective treatments for depression in the general population as well as in patients with a chronic disease. The aim of this study was to assess the efficacy of individual mindfulnessbased cognitive therapy (MBCT) and individual cognitive behavior therapy (CBT) in comparison with a waiting-list control condition for treating depressive symptoms in adults with type 1 or type 2 diabetes. RESEARCH DESIGN AND METHODSIn this randomized controlled trial, 94 outpatients with diabetes and comorbid depressive symptoms (i.e., Beck Depression Inventory-II [BDI-II] ‡14) were randomized to MBCT (n = 31), CBT (n = 32), or waiting list (n = 31). All participants completed written questionnaires and interviews at pre-and postmeasurement (3 months later). Primary outcome measure was severity of depressive symptoms (BDI-II and Toronto Hamilton Depression Rating Scale). Anxiety (Generalized Anxiety Disorder 7), well-being (Well-Being Index), diabetes-related distress (Problem Areas In Diabetes), and HbA 1c levels were assessed as secondary outcomes. RESULTSResults showed that participants receiving MBCT and CBT reported significantly greater reductions in depressive symptoms compared with patients in the waitinglist control condition (respectively, P = 0.004 and P < 0.001; d = 0.80 and 1.00; clinically relevant improvement 26% and 29% vs. 4%). Both interventions also had significant positive effects on anxiety, well-being, and diabetes-related distress. No significant effect was found on HbA 1c values. CONCLUSIONSBoth individual MBCT and CBT are effective in improving a range of psychological symptoms in individuals with type 1 and type 2 diabetes.

show abstract

“…However, since there are no reasons to assume a lack of efficacy for psychotherapy in these patients, treatment according to guidelines has to be provided. CBT is the psychotherapy with the best evidence for efficacy in patients with major depression [70]. In line with this, the recently published COPD-specific UK National Institute for Health and Care Excellence guidelines recommend ''identifying and managing anxiety and depression'' [60].…”

Section: Practical Consequencesmentioning

confidence: 95%

Depression and suicidality in COPD: understandable reaction or independent disorders?

Hegerl

Mergl

2014

European Respiratory Journal

View full text Add to dashboard Cite

Both depression and chronic obstructive pulmonary disease (COPD) are prevalent, severe and often comorbid disorders. There is a risk of undertreatment for depression in patients with COPD as depressive symptoms, including suicidal tendencies, can erroneously be conceptualised as an understandable reaction to COPD and not as signs of an independent depressive disorder. In this context, the comorbidity rates of COPD and depression, the risk of suicidal behaviour in patients with COPD, and the evidence base for pharmaco-and psychotherapy in these patients are reviewed.Because symptoms of depression and COPD overlap it remains unclear how far the prevalence of major depression in COPD exceeds that in the general population. The suicide risk appears to be increased in COPD. Methodological studies providing evidence for the antidepressant efficacy of antidepressants or psychotherapy in patients with COPD are lacking. Recommendations for clinicians on how to separate depression from an understandable reaction to COPD are provided.Given the profound effects of depression on quality of life, life expectancy, COPD prognosis and suicide risk it is important to carefully diagnose and treat depression in patients with COPD according to national guidelines. @ERSpublications Comorbid depression has profound effects on COPD prognosis and should not be seen as understandable reaction to COPD

show abstract

“…Although behavioral treatments for anxiety disorders are highly effective in reducing symptoms of anxiety (Butler, Chapman, Forman, & Beck, 2006;Hofmann & Smits, 2008;Tolin, 2010), many patients do not improve, drop out of treatment, or relapse (Arch & Craske, 2009;Clark et al, 2006;Davidson et al, 2004). Given the need to improve treatments, the goal of the current project is to translate neuroscience research to enhancing the effectiveness of exposure therapy for public speaking anxiety.…”

mentioning

confidence: 99%

Affect labeling enhances exposure effectiveness for public speaking anxiety

Niles

Craske

Lieberman

et al. 2015

Behaviour Research and Therapy

View full text Add to dashboard Cite

a b s t r a c tExposure is an effective treatment for anxiety but many patients do not respond fully. Affect labeling (labeling emotional experience) attenuates emotional responding. The current project examined whether affect labeling enhances exposure effectiveness in participants with public speaking anxiety. Participants were randomized to exposure with or without affect labeling. Physiological arousal and selfreported fear were assessed before and after exposure and compared between groups. Consistent with hypotheses, participants assigned to Affect Labeling, especially those who used more labels during exposure, showed greater reduction in physiological activation than Control participants. No effect was found for self-report measures. Also, greater emotion regulation deficits at baseline predicted more benefit in physiological arousal from exposure combined with affect labeling than exposure alone. The current research provides evidence that behavioral strategies that target prefrontal-amygdala circuitry can improve treatment effectiveness for anxiety and these effects are particularly pronounced for patients with the greatest deficits in emotion regulation.

show abstract

“…Un debate que continúa generando una sucesión de análisis y re-análisis de los estudios sobre la eficacia de las psicoterapias (ver Baardseth et al, 2013;Marcus, O'Connell, Norris y Sawaqdeh, 2014;Tolin, 2010). Significativamente, algunos de los meta-análisis, como el de Shapiro y Shapiro (1982) o de Smith y Glass (1977), son referenciados tanto en apoyo (por ejemplo, Wampold et al, 1997) como en contra (por ejemplo, Tolin, 2010) del veredicto de Dodo.…”

Section: La Historia Del Veredicto De Dodounclassified

¡Enjaulad a Dodo, por favor! El cuento de que todas las psicoterapias son igual de eficaces

González‐Blanch¹,

Carral-Fernández²

2017

Pap. Psicol.

View full text Add to dashboard Cite

A r t í c u l o sPapeles del Psicólogo / Psychologist Papers, 2017. Vol. 38(2), pp. 94-106 https://doi.org/10.23923/pap.psicol2017.2828 http://www.papelesdelpsicologo.es http://www.psychologistpapers.com 94 odo es el pájaro más citado de la Psicología. Se trata de un personaje de Alicia en el País de la Maravillas que resuelve una carrera con un planteamiento alocado (cada uno empezaba por donde y cuando quería, y paraba a su antojo) con la sentencia "Todos han ganado, y todos deben tener premio". En Psicología, el veredicto del pájaro Dodo ha valido para representar metafóricamente la idea de que todas las psicoterapias obtienen resultados equivalentes. De aquí se ha postulado que lo que prevalece en la eficacia de los tratamientos son los factores comunes referidos al paciente, al terapeuta, a la relación entre ambos, a la estructura de la terapia o al proceso terapéutico en sí, más que los componentes específicos de cada orientación terapéutica (Wampold, 2007).El presente artículo pretende repasarla historia de este debate, resaltar algunas de las limitaciones que deben contener las conclusiones que de él se pueden obtener y, por último, argumentar sobre los motivos por los que el debate sigue, como en el cuento, sin un claro final. LA HISTORIA DEL VEREDICTO DE DODOEl primer referente de este veredicto de Dodo se encuentra en 1936 un artículo de Rosenzweig (1936), que contiene la primera formulación de la preponderancia de los factores comunes en psicoterapia. Unas cuantas décadas después, la idea fue rescatada en una revisión cualitativa de la literatura que concluye que no existen efectos diferenciales entre los tratamientos (Luborsky, Singer y Luborsky, 1975). Smith y Glass (1977) fueron los primeros en hacer la primera revisión cuantitativa (meta-análisis) tratando de resumir los datos de 375 estudios. Concluyeron, por una parte, que todas las psicoterapias eran más eficaces que el no-tratamiento; por otra, que las diferencias entre las escuelas eran en la práctica despreciables, por lo que, en definitiva, no estaba justificada la reivindicación de que unas eran superiores a otras. Aunque el tamaño del efecto entre terapias es grande para unas (0.91 para la desensibilización sistemática) y pequeño-medio en otras (0.26 para la Gestalt), la conclusión se sostiene en la agrupación de las terapias entre conductuales y no-conductuales (entre las que incluye, junto a la rogeriana y las psicodinámicas, algunas cognitivas). Quizá porque el meta-análisis no había logrado la veneración que tiene en la actualidad, Hans Eysenk, conocido por su polémica afirmación de la ineficacia de todas las psicoterapias (salvo la conductual), se refirió a este estudio como una "mega-

show abstract

“…When comparing the efficacy of different interventions for sexual dysfunction, we hope that researchers will utilize these lessons gained from past attempts in other areas, such as those of Tolin (2010) discussed above, to compare interventions. Specifically, any legitimate comparisons of different treatments should take care to correctly categorize interventions (e.g., as CBT vs. mindfulness vs. combined treatments), account for study quality, and generally minimize error variance to allow for detection of true effects.…”

Section: Other Considerations For Researchers Evaluating Psychologicamentioning

confidence: 99%

Challenges in Designing Psychological Treatment Studies for Sexual Dysfunction

Brotto

Basson

Chivers

et al. 2016

Journal of Sex & Marital Therapy

View full text Add to dashboard Cite

Is cognitive–behavioral therapy more effective than other therapies?A meta-analytic review

Cited by 529 publications

References 71 publications

Individual Mindfulness-Based Cognitive Therapy and Cognitive Behavior Therapy for Treating Depressive Symptoms in Patients With Diabetes: Results of a Randomized Controlled Trial

Depression and suicidality in COPD: understandable reaction or independent disorders?

Affect labeling enhances exposure effectiveness for public speaking anxiety

¡Enjaulad a Dodo, por favor! El cuento de que todas las psicoterapias son igual de eficaces

Challenges in Designing Psychological Treatment Studies for Sexual Dysfunction

Contact Info

Product

Resources

About